|
85
|
231
|
4xkbA |
Crystal structure of genomes uncoupled 4 (gun4) in complex with deuteroporphyrin ix |
|
275
|
945
|
4wwnA |
Crystal structure of human pi3k-gamma in complex with (s)-n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine amg319 inhibitor |
|
37
|
141
|
4xeiG |
Orthorhombic isomorph of bovine arp2/3 complex |
|
263
|
917
|
4xe0A |
Idelalisib bound to the p110 subunit of pi3k delta |
|
263
|
944
|
4wwoA |
Crystal structure of human pi3k-gamma in complex with phenylquinoline inhibitor n-{(1s)-1-[8-chloro-2-(3-fluorophenyl)quinolin-3-yl]ethyl}-9h-purin-6-amine |
|
268
|
717
|
4xifA |
Human ogt in complex with udp-5s-glcnac and substrate peptide (keratin-7) |
|
71
|
177
|
4xi0A |
Mama 41-end from desulfovibrio magneticus rs-1 |
|
206
|
589
|
4uwhA |
Discovery of (2s)-8-((3r)-3-methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2h-pyrimido(1,2-a)pyrimidin-6- one: a novel potent and selective inhibitor of vps34 for the treatment of solid tumors |
|
111
|
360
|
4w9rA |
Crystal structure of uncharacterised protein coch_1243 from capnocytophaga ochracea dsm 7271 |
|
272
|
940
|
4tv3A |
Isolated p110a subunit of pi3ka provides a platform for structure-based drug design |
|
178
|
526
|
4ui9K |
Atomic structure of the human anaphase-promoting complex |
|
89
|
207
|
4x8qA |
X-ray crystal structure of alkd2 from streptococcus mutans |
|
107
|
256
|
4wnfA |
Crystal structure of the oxidized tpr domain of lgn in complex with frmpd4/preso1 at 2.9 angstrom resolution |
|
149
|
336
|
4wneA |
Crystal structure of the tpr domain of lgn in complex with frmpd4/preso1 at 2.0 angstrom resolution |
|
75
|
221
|
4uucA |
Crystal structure of human asb11 ankyrin repeat domain |
|
85
|
262
|
4uqxA |
Coevolution of the atpase clpv, the tssb-tssc sheath and the accessory hsie protein distinguishes two type vi secretion classes |
|
154
|
337
|
4wndA |
Crystal structure of the tpr domain of lgn in complex with frmpd4/preso1 at 1.5 angstrom resolution |
|
144
|
337
|
4wngA |
Crystal structure of the tpr domain of lgn in complex with frmpd4/preso1 at 2.1 angstrom resolution |
|
182
|
588
|
4uwfA |
Discovery of (2s)-8-((3r)-3-methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2h-pyrimido(1,2-a)pyrimidin-6- one: a novel potent and selective inhibitor of vps34 for the treatment of solid tumors |
|
185
|
532
|
4ui9C |
Atomic structure of the human anaphase-promoting complex |
|
179
|
532
|
4ui9J |
Atomic structure of the human anaphase-promoting complex |
|
195
|
583
|
4uwkA |
Discovery of (2s)-8-((3r)-3-methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2h-pyrimido(1,2-a)pyrimidin-6- one: a novel potent and selective inhibitor of vps34 for the treatment of solid tumors |
|
62
|
160
|
4v3iA |
Crystal structure of tssl from vibrio cholerae. |
|
88
|
257
|
4uqyA |
Coevolution of the atpase clpv, the tssb-tssc sheath and the accessory hsie protein distinguishes two type vi secretion classes |
|
191
|
584
|
4uwlA |
Discovery of (2s)-8-((3r)-3-methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2h-pyrimido(1,2-a)pyrimidin-6- one: a novel potent and selective inhibitor of vps34 for the treatment of solid tumors |
|
265
|
940
|
4tuuA |
Isolated p110a subunit of pi3ka provides a platform for structure-based drug design |
|
88
|
258
|
4uqzA |
Coevolution of the atpase clpv, the tssb-tssc sheath and the accessory hsie protein distinguishes two type vi secretion classes |
|
145
|
429
|
4wuyA |
Crystal structure of protein lysine methyltransferase smyd2 in complex with lly-507, a cell-active, potent and selective inhibitor |
|
195
|
584
|
4uwgA |
Discovery of (2s)-8-((3r)-3-methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4-dihydro-2h-pyrimido(1,2-a)pyrimidin-6- one: a novel potent and selective inhibitor of vps34 for the treatment of solid tumors |
|
53
|
156
|
4u8vD |
Coupling of remote alternating-access transport mechanisms for protons and substrates in the multidrug efflux pump acrb |
|
116
|
328
|
4u0zA |
Eukaryotic fic domain containing protein with bound apcpp |
|
219
|
607
|
4rvbA |
Crystal structure analysis of the human leukotriene a4 hydrolase |
|
120
|
327
|
4u04A |
Structure of a eukaryotic fic domain containing protein |
|
102
|
299
|
4trqA |
Crystal structure of sac3/thp1/sem1 |
|
127
|
334
|
4u0uA |
Wild type eukaryotic fic domain containing protein with adp |
|
53
|
156
|
4u96D |
Coupling of remote alternating-access transport mechanisms for protons and substrates in the multidrug efflux pump acrb |
|
127
|
326
|
4u0sA |
Structure of eukaryotic fic domain containing protein with adp |
|
146
|
490
|
4u8hA |
Crystal structure of mammalian period-cryptochrome complex |
|
63
|
156
|
4txpA |
Crystal structure of lip5 n-terminal domain |
|
53
|
156
|
4u95D |
Coupling of remote alternating-access transport mechanisms for protons and substrates in the multidrug efflux pump acrb |
|
168
|
482
|
4u63A |
Crystal structure of a bacterial class iii photolyase from agrobacterium tumefaciens at 1.67a resolution |
|
50
|
156
|
4u8yD |
Coupling of remote alternating-access transport mechanisms for protons and substrates in the multidrug efflux pump acrb |
|
68
|
162
|
4txqA |
Crystal structure of lip5 n-terminal domain complexed with chmp1b mim |
|
67
|
159
|
4txrA |
Crystal structure of lip5 n-terminal domain complexed with chmp1b mim and chmp5 mim |
|
218
|
607
|
4rsyA |
Crystal structures of the human leukotriene a4 hydrolase complex with a potential inhibitor h7 |
|
66
|
163
|
4u7eB |
The crystal structure of the complex of lip5 ntd and ist1 mim |
|
122
|
326
|
4u07A |
Atp bound to eukaryotic fic domain containing protein |
|
41
|
122
|
4tumA |
Crystal structure of ankyrin repeat domain of akr2 |
|
156
|
497
|
4rg9A |
Crystal structure of apc3-apc16 complex (selenomethionine derivative) |
|
272
|
949
|
4ps8A |
Structure of pi3k gamma in complex with n-[6-(5,6-dimethoxypyridin-3-yl)-1,3-benzothiazol-2-yl]acetamide |
